DelistingApr 29, 2026, 04:40 PM
INVO Fertility Receives Nasdaq Delisting Notice for Late 10-K
AI Summary
INVO Fertility, Inc. received a notice from Nasdaq on April 23, 2026, indicating non-compliance with listing rules due to the late filing of its Annual Report on Form 10-K for the year ended December 31, 2025. The notice has no immediate effect on the company's stock listing, and IVF continues to trade on The Nasdaq Capital Market. The company has 60 days to submit a plan to regain compliance, with a potential extension of up to 180 days. The delay is attributed to additional time needed to review complex accounting matters, including tax provision, warrant, and variable interest entity accounting.
Key Highlights
- INVO Fertility received Nasdaq notice on April 23, 2026, for late 2025 Form 10-K filing.
- Company failed to satisfy Nasdaq Listing Rule 5250(c)(1).
- The notice has no immediate effect on the listing of IVF common stock.
- INVO Fertility has 60 calendar days to submit a plan to regain compliance.
- Nasdaq may grant an exception of up to 180 calendar days, until October 13, 2026.
- Delay in filing is due to complex accounting matters, including tax provision and warrant accounting.
- Company expects to file the Annual Report as soon as practicable.